NCT03283696 A Study of Olaratumab (LY3012207), Doxorubicin, and Ifosfamide in Participants With Advanced or Metastatic Soft Tissue Sarcoma Status COMPLETED Phase PHASE1
NCT03275311 Evolution of the Therapeutic Care in Metastatic Breast Cancer From 2008 Status RECRUITING Phase N/A
NCT03270644 A Study of Lasmiditan and Propranolol in Healthy Participants Status COMPLETED Phase PHASE1
NCT03267732 A Study to Evaluate the Pharmacokinetics in Participants After Dosing With Pegilodecakin (LY3500518) Status COMPLETED Phase PHASE1
NCT03259490 This Study Tests Whether Taking the Medicines Empagliflozin, Linagliptin, and Metformin Together in 1 Pill is the Same as Taking Them in Separate Pills. The Study is Done in Healthy Men and Women and Measures the Amount of Each Medicine in the Blood Status COMPLETED Phase PHASE1
NCT03252015 A Study of Multiple Doses of Lasmiditan in Healthy Participants Status COMPLETED Phase PHASE1
NCT03232983 A Study of LY900014 Formulation at Different Injection Sites in Healthy Participants Status COMPLETED Phase PHASE1
NCT03220646 Abemaciclib (LY2835219) in Patients With Recurrent Primary Brain Tumors Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT03220126 A Study to Assess the Amount of LY3074828 That Gets Into the Body When Given With LY9999QS, in Healthy Participants Status COMPLETED Phase PHASE1
NCT03214380 A Study of LY900014 Compared to Insulin Lispro in Participants With Type 2 Diabetes Status COMPLETED Phase PHASE3
NCT03206177 Paclitaxel/Carboplatin + Galunisertib for Patients With Carcinosarcoma of the Uterus or Ovary Status COMPLETED Phase PHASE1
NCT03188510 A Study of Two Different Formulations of LY3074828 in Healthy Participants Status COMPLETED Phase PHASE1
NCT03166124 A Study of LY900014 in Elderly and Younger Adult Participants With Type 1 Diabetes Mellitus Status COMPLETED Phase PHASE1
NCT03157128 A Study of Selpercatinib (LOXO-292) in Participants With Advanced Solid Tumors, RET Fusion-Positive Solid Tumors, and Medullary Thyroid Cancer (LIBRETTO-001) Status ACTIVE_NOT_RECRUITING Phase PHASE1/PHASE2
NCT03155997 Endocrine Therapy With or Without Abemaciclib (LY2835219) Following Surgery in Participants With Breast Cancer Status ACTIVE_NOT_RECRUITING Phase PHASE3